New drug combo may boost stem cell collection for rare immune disease
NCT ID NCT03055247
First seen Sep 30, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This study tests a combination of ibuprofen, G-CSF, and plerixafor to collect stem cells from people with X-linked chronic granulomatous disease (X-CGD), a rare immune disorder. The goal is to see if this drug mix is safe and effective at gathering enough stem cells for future gene therapy. Only 3 adults aged 18-45 with X-CGD will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRANULOMATOUS DISEASE X-LINKED (X-CGD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ospedale Pediatrico Bambino Gesù
RECRUITINGRome, Lazio, 00165, Italy
Contact
Contact
-
Ospedale San Raffaele
RECRUITINGMilan, Lombardy, 20132, Italy
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.